5-AMINO-2-CHLORO-4-FLUOROBENZONITRILE, 95%, 100mg

8-BROMO-5-CHLORO-[1,2,4]TRIAZOLO[1,5-A]PYRIDINE, 95.0%, 100mg

2-(2-Chlorophenyl)piperazine, 97.0%, 250mg

5-CHLORO-1-CYCLOPROPYL-4-NITRO-1H-PYRAZOLE, 95.0%, 1g

5-Bromo-2,3-dihydro-1-benzofuran-2-one, 97%, 500mg

(S)-1-Isopropylpyrrolidin-3-amine dihydrochloride, 95.0%, 10g

Phase contrast slide set with 20x and S100x PLPHi IOS infinity corrected objectives and phase contrast rings for 20x/S100x

1-(4-FLUOROPHENYL)-3-(PHENYLSULFONYL)-1H-PYRROLO[2,3-B]QUINOXALIN-2-AMINE, 95%, 10mg

((2R,3R,4R,5R)-3-(benzoyloxy)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-4-methyltetrahydrofuran-2-yl)methyl benzoate, 98%, 250mg

3-Oxo-3-(tetrahydro-2H-pyran-4-yl)propanenitrile, 95.0%, 1g

4-Methoxyphenyltriflate, 99.0%, 100g

C-(1,3-Dimethyl-pyrrolidin-3-yl)-methylamine, 95.0%, 1g

2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4'-methoxy benzophenone, 97.0%, 1g